# Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

> **NCT06128980** · PHASE2,PHASE3 · RECRUITING · sponsor: **Herlev and Gentofte Hospital** · enrollment: 348 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Heart Rhythm Disorder

## Interventions

- **DRUG:** GDMT

## Key facts

- **NCT ID:** NCT06128980
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-09
- **Primary completion:** 2028-01
- **Final completion:** 2032-01
- **Target enrollment:** 348 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06128980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06128980, "Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06128980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*